{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:52:24Z","timestamp":1792687944250,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,6]]},"DOI":"10.7759\/cureus.100950","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T23:29:55Z","timestamp":1767742195000},"source":"Crossref","is-referenced-by-count":3,"title":["Artificial Intelligence in Hematologic Malignancies: Opportunities, Challenges, and Clinical Integration"],"prefix":"10.7759","author":[{"given":"Aya","family":"Salem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Teama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan A","family":"Kassem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niyousha","family":"Vakilzadehian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arig","family":"Mahmoud Abdelaziz Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharaneswar","family":"Venugopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"M. Khalifa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-540-75387-2_149","article-title":"Hematological Neoplasms","author":"Zierhut M","year":"2016","unstructured":"Zierhut M, Haen SP, Moehle R, et al.. Hematological Neoplasms. Intraocular Inflammation. Springer, Berlin, Heidelberg; 2016. 10.1007\/978-3-540-75387-2_149"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3207-7","article-title":"A systematic review of prognostic factors at the end of life for people with a hematological malignancy","volume":"17","author":"Button E","year":"2017","unstructured":"Button E, Chan RJ, Chambers S, Butler J, Yates P. A systematic review of prognostic factors at the end of life for people with a hematological malignancy. BMC Cancer. 2017, 17:213. 10.1186\/s12885-017-3207-7","journal-title":"BMC Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdl443","article-title":"Epidemiology of hematological malignancies","volume":"18","author":"Rodriguez-Abreu D","year":"2007","unstructured":"Rodriguez-Abreu D, Bordoni A, Zucca E. Epidemiology of hematological malignancies. Ann Oncol. 2007, 18:i3-8. 10.1093\/annonc\/mdl443","journal-title":"Ann Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00007","article-title":"Critical role of microRNA-21 in the pathogenesis of liver diseases","volume":"7","author":"Zhang T","year":"2020","unstructured":"Zhang T, Yang Z, Kusumanchi P, Han S, Liangpunsakul S. Critical role of microRNA-21 in the pathogenesis of liver diseases. Front Med (Lausanne). 2020, 7:7. 10.3389\/fmed.2020.00007","journal-title":"Front Med (Lausanne)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/20552076241247963","article-title":"Application of machine learning in the management of lymphoma: current practice and future prospects","volume":"10","author":"Yuan J","year":"2024","unstructured":"Yuan J, Zhang Y, Wang X. Application of machine learning in the management of lymphoma: current practice and future prospects. Digit Health. 2024, 10:20552076241247963. 10.1177\/20552076241247963","journal-title":"Digit Health"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2011.11.036","article-title":"Radiomics: extracting more information from medical images using advanced feature analysis","volume":"48","author":"Lambin P","year":"2012","unstructured":"Lambin P, Rios-Velazquez E, Leijenaar R, et al.. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer. 2012, 48:441-6. 10.1016\/j.ejca.2011.11.036","journal-title":"Eur J Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2017.04.006","article-title":"The potential value of preoperative MRI texture and shape analysis in grading meningiomas: a preliminary investigation","volume":"10","author":"Yan PF","year":"2017","unstructured":"Yan PF, Yan L, Hu TT, Xiao DD, Zhang Z, Zhao HY, Feng J. The potential value of preoperative MRI texture and shape analysis in grading meningiomas: a preliminary investigation. Transl Oncol. 2017, 10:570-7. 10.1016\/j.tranon.2017.04.006","journal-title":"Transl Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-019-06378-3","article-title":"Noncontrast computer tomography-based radiomics model for predicting intracerebral hemorrhage expansion: preliminary findings and comparison with conventional radiological model","volume":"30","author":"Xie H","year":"2020","unstructured":"Xie H, Ma S, Wang X, Zhang X. Noncontrast computer tomography-based radiomics model for predicting intracerebral hemorrhage expansion: preliminary findings and comparison with conventional radiological model. Eur Radiol. 2020, 30:87-98. 10.1007\/s00330-019-06378-3","journal-title":"Eur Radiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1148\/rg.2017170056","article-title":"CT texture analysis: definitions, applications, biologic correlates, and challenges","volume":"37","author":"Lubner MG","year":"2017","unstructured":"Lubner MG, Smith AD, Sandrasegaran K, Sahani DV, Pickhardt PJ. CT texture analysis: definitions, applications, biologic correlates, and challenges. Radiographics. 2017, 37:1483-503. 10.1148\/rg.2017170056","journal-title":"Radiographics"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2020.03.032","article-title":"Machine Learning in oncology: a clinical appraisal","volume":"481","author":"Cuocolo R","year":"2020","unstructured":"Cuocolo R, Caruso M, Perillo T, Ugga L, Petretta M. Machine Learning in oncology: a clinical appraisal. Cancer Lett. 2020, 481:55-62. 10.1016\/j.canlet.2020.03.032","journal-title":"Cancer Lett"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01614-0","article-title":"AI in health and medicine","volume":"28","author":"Rajpurkar P","year":"2022","unstructured":"Rajpurkar P, Chen E, Banerjee O, Topol EJ. AI in health and medicine. Nat Med. 2022, 28:31-8. 10.1038\/s41591-021-01614-0","journal-title":"Nat Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.48550\/arXiv.2212.11279","article-title":"Annotated history of modern AI and deep learning","volume":"2212","author":"Schmidhuber J","year":"2022","unstructured":"Schmidhuber J. Annotated history of modern AI and deep learning. arXiv. 2022, 2212:11279. 10.48550\/arXiv.2212.11279","journal-title":"arXiv"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-023-04667-5","article-title":"An overview and a roadmap for artificial intelligence in hematology and oncology","volume":"149","author":"R\u00f6sler W","year":"2023","unstructured":"R\u00f6sler W, Altenbuchinger M, Bae\u00dfler B, et al.. An overview and a roadmap for artificial intelligence in hematology and oncology. J Cancer Res Clin Oncol. 2023, 149:7997-8006. 10.1007\/s00432-023-04667-5","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-00327-9","article-title":"Designing deep learning studies in cancer diagnostics","volume":"21","author":"Kleppe A","year":"2021","unstructured":"Kleppe A, Skrede OJ, De Raedt S, Liest\u00f8l K, Kerr DJ, Danielsen HE. Designing deep learning studies in cancer diagnostics. Nat Rev Cancer. 2021, 21:199-211. 10.1038\/s41568-020-00327-9","journal-title":"Nat Rev Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-022-00436-4","article-title":"Artificial intelligence in histopathology: enhancing cancer research and clinical oncology","volume":"3","author":"Shmatko A","year":"2022","unstructured":"Shmatko A, Ghaffari Laleh N, Gerstung M, Kather JN. Artificial intelligence in histopathology: enhancing cancer research and clinical oncology. Nat Cancer. 2022, 3:1026-38. 10.1038\/s43018-022-00436-4","journal-title":"Nat Cancer"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/path.5898","article-title":"Artificial intelligence to identify genetic alterations in conventional histopathology","volume":"257","author":"Cifci D","year":"2022","unstructured":"Cifci D, Foersch S, Kather JN. Artificial intelligence to identify genetic alterations in conventional histopathology. J Pathol. 2022, 257:430-44. 10.1002\/path.5898","journal-title":"J Pathol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering7040120","article-title":"Detection and classification of immature leukocytes for diagnosis of acute myeloid leukemia using random forest algorithm","volume":"7","author":"Dasariraju S","year":"2020","unstructured":"Dasariraju S, Huo M, McCalla S. Detection and classification of immature leukocytes for diagnosis of acute myeloid leukemia using random forest algorithm. Bioengineering (Basel). 2020, 7:10.3390\/bioengineering7040120","journal-title":"Bioengineering (Basel)"},{"key":"ref18","article-title":"Leukemia","author":"Chennamadhavuni A","year":"2023","unstructured":"Chennamadhavuni A, Iyengar V, Mukkamalla SKR, et al.. Leukemia. StatPearls, Treasure Island, FL; 2023."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-024-00525-x","article-title":"Acute lymphoblastic leukaemia","volume":"10","author":"Pagliaro L","year":"2024","unstructured":"Pagliaro L, Chen SJ, Herranz D, et al.. Acute lymphoblastic leukaemia. Nat Rev Dis Primers. 2024, 10:41. 10.1038\/s41572-024-00525-x","journal-title":"Nat Rev Dis Primers"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a034819","article-title":"Epidemiology and etiology of leukemia and lymphoma","volume":"10","author":"Bispo JA","year":"2020","unstructured":"Bispo JA, Pinheiro PS, Kobetz EK. Epidemiology and etiology of leukemia and lymphoma. Cold Spring Harb Perspect Med. 2020, 10:10.1101\/cshperspect.a034819","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury JD","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, et al.. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms. Leukemia. 2022, 36:1703-19. 10.1038\/s41375-022-01613-1","journal-title":"Leukemia"},{"key":"ref22","article-title":"The 5(th) Edition of the World Health Organization Classification of Hematolymphoid Tumors","author":"Li W","year":"2022","unstructured":"Li W. The 5(th) Edition of the World Health Organization Classification of Hematolymphoid Tumors. Leukemia. Exon Publications, 2022; 2022. Brisbane, Australia."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.13089","article-title":"Machine learning applications in the diagnosis of leukemia: current trends and future directions","volume":"41","author":"Salah HT","year":"2019","unstructured":"Salah HT, Muhsen IN, Salama ME, Owaidah T, Hashmi SK. Machine learning applications in the diagnosis of leukemia: current trends and future directions. Int J Lab Hematol. 2019, 41:717-25. 10.1111\/ijlh.13089","journal-title":"Int J Lab Hematol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002997","article-title":"Application of machine learning in the management of acute myeloid leukemia: current practice and future prospects","volume":"4","author":"Eckardt JN","year":"2020","unstructured":"Eckardt JN, Bornh\u00e4user M, Wendt K, Middeke JM. Application of machine learning in the management of acute myeloid leukemia: current practice and future prospects. Blood Adv. 2020, 4:6077-85. 10.1182\/bloodadvances.2020002997","journal-title":"Blood Adv"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/nu12092652","article-title":"Logistic LASSO regression for dietary intakes and breast cancer","volume":"12","author":"McEligot AJ","year":"2020","unstructured":"McEligot AJ, Poynor V, Sharma R, Panangadan A. Logistic LASSO regression for dietary intakes and breast cancer. Nutrients. 2020, 12:10.3390\/nu12092652","journal-title":"Nutrients"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13071330","article-title":"Applications of machine learning in chronic myeloid leukemia","volume":"13","author":"Elhadary M","year":"2023","unstructured":"Elhadary M, Elsabagh AA, Ferih K, et al.. Applications of machine learning in chronic myeloid leukemia. Diagnostics (Basel). 2023, 13:10.3390\/diagnostics13071330","journal-title":"Diagnostics (Basel)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics9030104","article-title":"Identification of leukemia subtypes from microscopic images using convolutional neural network","volume":"9","author":"Ahmed N","year":"2019","unstructured":"Ahmed N, Yigit A, Isik Z, Alpkocak A. Identification of leukemia subtypes from microscopic images using convolutional neural network. Diagnostics (Basel). 2019, 9:10.3390\/diagnostics9030104","journal-title":"Diagnostics (Basel)"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000023154","article-title":"AML, ALL, and CML classification and diagnosis based on bone marrow cell morphology combined with convolutional neural network: a STARD compliant diagnosis research","volume":"99","author":"Huang F","year":"2020","unstructured":"Huang F, Guang P, Li F, Liu X, Zhang W, Huang W. AML, ALL, and CML classification and diagnosis based on bone marrow cell morphology combined with convolutional neural network: a STARD compliant diagnosis research. Medicine (Baltimore). 2020, 99:e23154. 10.1097\/MD.0000000000023154","journal-title":"Medicine (Baltimore)"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2021.06.025","article-title":"Accurate machine-learning-based classification of leukemia from blood smear images","volume":"21","author":"Dese K","year":"2021","unstructured":"Dese K, Raj H, Ayana G, Yemane T, Adissu W, Krishnamoorthy J, Kwa T. Accurate machine-learning-based classification of leukemia from blood smear images. Clin Lymphoma Myeloma Leuk. 2021, 21:e903-14. 10.1016\/j.clml.2021.06.025","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/s12911-022-01980-w","article-title":"Comparing machine learning algorithms to predict 5-year survival in patients with chronic myeloid leukemia","volume":"22","author":"Shanbehzadeh M","year":"2022","unstructured":"Shanbehzadeh M, Afrash MR, Mirani N, Kazemi-Arpanahi H. Comparing machine learning algorithms to predict 5-year survival in patients with chronic myeloid leukemia. BMC Med Inform Decis Mak. 2022, 22:236. 10.1186\/s12911-022-01980-w","journal-title":"BMC Med Inform Decis Mak"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1186\/s12911-023-02408-9","article-title":"Multiple machine-learning tools identifying prognostic biomarkers for acute myeloid leukemia","volume":"24","author":"Cheng Y","year":"2024","unstructured":"Cheng Y, Yang X, Wang Y, Li Q, Chen W, Dai R, Zhang C. Multiple machine-learning tools identifying prognostic biomarkers for acute myeloid leukemia. BMC Med Inform Decis Mak. 2024, 24:2. 10.1186\/s12911-023-02408-9","journal-title":"BMC Med Inform Decis Mak"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000002292","article-title":"Can machine learning models predict asparaginase-associated pancreatitis in childhood acute lymphoblastic leukemia","volume":"44","author":"Nielsen RL","year":"2022","unstructured":"Nielsen RL, Wolthers BO, Helenius M, et al.. Can machine learning models predict asparaginase-associated pancreatitis in childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2022, 44:e628-36. 10.1097\/MPH.0000000000002292","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3037","article-title":"Improving survival of 3760 patients with lymphoma: experience of an academic center over two decades","volume":"9","author":"Liu W","year":"2020","unstructured":"Liu W, Ji X, Song Y, et al.. Improving survival of 3760 patients with lymphoma: experience of an academic center over two decades. Cancer Med. 2020, 9:3765-74. 10.1002\/cam4.3037","journal-title":"Cancer Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3390\/biom11060793","article-title":"Translational applications of artificial intelligence and machine learning for diagnostic pathology in lymphoid neoplasms: a comprehensive and evolutive analysis","volume":"11","author":"Moran-Sanchez J","year":"2021","unstructured":"Moran-Sanchez J, Santisteban-Espejo A, Martin-Piedra MA, Perez-Requena J, Garcia-Rojo M. Translational applications of artificial intelligence and machine learning for diagnostic pathology in lymphoid neoplasms: a comprehensive and evolutive analysis. Biomolecules. 2021, 11:10.3390\/biom11060793","journal-title":"Biomolecules"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13102419","article-title":"Deep learning for the classification of non-Hodgkin lymphoma on histopathological images","volume":"13","author":"Steinbuss G","year":"2021","unstructured":"Steinbuss G, Kriegsmann M, Zgorzelski C, et al.. Deep learning for the classification of non-Hodgkin lymphoma on histopathological images. Cancers (Basel). 2021, 13:10.3390\/cancers13102419","journal-title":"Cancers (Basel)"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1080\/02713683.2023.2246696","article-title":"Machine learning model with texture analysis for automatic classification of histopathological images of ocular adnexal mucosa-associated lymphoid tissue lymphoma of two different origins","volume":"48","author":"Tagami M","year":"2023","unstructured":"Tagami M, Nishio M, Katsuyama-Yoshikawa A, et al.. Machine learning model with texture analysis for automatic classification of histopathological images of ocular adnexal mucosa-associated lymphoid tissue lymphoma of two different origins. Curr Eye Res. 2023, 48:1195-202. 10.1080\/02713683.2023.2246696","journal-title":"Curr Eye Res"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-023-08181-9","article-title":"Can deep learning replace histopathological examinations in the differential diagnosis of cervical lymphadenopathy?","volume":"281","author":"Can S","year":"2024","unstructured":"Can S, T\u00fcrk \u00d6, Ayral M, Kozan G, Ar\u0131 H, Akda\u011f M, Baylan MY. Can deep learning replace histopathological examinations in the differential diagnosis of cervical lymphadenopathy?. Eur Arch Otorhinolaryngol. 2024, 281:359-67. 10.1007\/s00405-023-08181-9","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-023-03326-y","article-title":"Machine-learning-based classification of diffuse large B-cell lymphoma patients by a 7-mRNA signature enriched with immune infiltration and cell cycle","volume":"26","author":"Zhuang X","year":"2024","unstructured":"Zhuang X, Liu B, Long J, et al.. Machine-learning-based classification of diffuse large B-cell lymphoma patients by a 7-mRNA signature enriched with immune infiltration and cell cycle. Clin Transl Oncol. 2024, 26:936-50. 10.1007\/s12094-023-03326-y","journal-title":"Clin Transl Oncol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-020-05080-7","article-title":"Fully automatic segmentation of diffuse large B cell lymphoma lesions on 3D FDG-PET\/CT for total metabolic tumour volume prediction using a convolutional neural network","volume":"48","author":"Blanc-Durand P","year":"2021","unstructured":"Blanc-Durand P, J\u00e9gou S, Kanoun S, et al.. Fully automatic segmentation of diffuse large B cell lymphoma lesions on 3D FDG-PET\/CT for total metabolic tumour volume prediction using a convolutional neural network. Eur J Nucl Med Mol Imaging. 2021, 48:1362-70. 10.1007\/s00259-020-05080-7","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13163998","article-title":"New approaches in characterization of lesions dissemination in DLBCL patients on baseline PET\/CT","volume":"13","author":"Cottereau AS","year":"2021","unstructured":"Cottereau AS, Meignan M, Nioche C, et al.. New approaches in characterization of lesions dissemination in DLBCL patients on baseline PET\/CT. Cancers (Basel). 2021, 13:10.3390\/cancers13163998","journal-title":"Cancers (Basel)"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2022.2131415","article-title":"[(18)F]FDG-PET\/CT volumetric parameters can predict outcome in untreated mantle cell lymphoma","volume":"64","author":"Vergote VK","year":"2023","unstructured":"Vergote VK, Verhoef G, Janssens A, et al.. [(18)F]FDG-PET\/CT volumetric parameters can predict outcome in untreated mantle cell lymphoma. Leuk Lymphoma. 2023, 64:161-70. 10.1080\/10428194.2022.2131415","journal-title":"Leuk Lymphoma"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.242412","article-title":"Deep-learning 18F-FDG uptake classification enables total metabolic tumor volume estimation in diffuse large B-cell lymphoma","volume":"62","author":"Capobianco N","year":"2021","unstructured":"Capobianco N, Meignan M, Cottereau AS, et al.. Deep-learning 18F-FDG uptake classification enables total metabolic tumor volume estimation in diffuse large B-cell lymphoma. J Nucl Med. 2021, 62:30-6. 10.2967\/jnumed.120.242412","journal-title":"J Nucl Med"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1200\/CCI.18.00025","article-title":"Optimizing outcome prediction in diffuse large B-cell lymphoma by use of machine learning and nationwide lymphoma registries: a Nordic lymphoma group study","volume":"2","author":"Biccler JL","year":"2018","unstructured":"Biccler JL, Eloranta S, de Nully Brown P, et al.. Optimizing outcome prediction in diffuse large B-cell lymphoma by use of machine learning and nationwide lymphoma registries: a Nordic lymphoma group study. JCO Clin Cancer Inform. 2018, 2:1-13. 10.1200\/CCI.18.00025","journal-title":"JCO Clin Cancer Inform"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.patrec.2021.07.004","article-title":"Machine learning in precision medicine to preserve privacy via encryption","volume":"151","author":"Briguglio W","year":"2021","unstructured":"Briguglio W, Moghaddam P, Yousef WA, Traor\u00e9 I, Mamun M. Machine learning in precision medicine to preserve privacy via encryption. Pattern Recognit Lett. 2021, 151:148-54. 10.1016\/j.patrec.2021.07.004","journal-title":"Pattern Recognit Lett"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-019-0122-6","article-title":"Deep learning: new computational modelling techniques for genomics","volume":"20","author":"Eraslan G","year":"2019","unstructured":"Eraslan G, Avsec \u017d, Gagneur J, Theis FJ. Deep learning: new computational modelling techniques for genomics. Nat Rev Genet. 2019, 20:389-403. 10.1038\/s41576-019-0122-6","journal-title":"Nat Rev Genet"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1007\/s43441-021-00277-w","article-title":"Streamlined operational approaches and use of e-technologies in clinical trials: Beat Acute Myeloid Leukemia Master Trial","volume":"55","author":"Rosenberg L","year":"2021","unstructured":"Rosenberg L, Levaux H, Levine RL, et al.. Streamlined operational approaches and use of e-technologies in clinical trials: Beat Acute Myeloid Leukemia Master Trial. Ther Innov Regul Sci. 2021, 55:926-35. 10.1007\/s43441-021-00277-w","journal-title":"Ther Innov Regul Sci"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.214957","article-title":"Novel insights into the genetics and epigenetics of MALT lymphoma unveiled by next generation sequencing analyses","volume":"104","author":"Cascione L","year":"2019","unstructured":"Cascione L, Rinaldi A, Bruscaggin A, et al.. Novel insights into the genetics and epigenetics of MALT lymphoma unveiled by next generation sequencing analyses. Haematologica. 2019, 104:e558-61. 10.3324\/haematol.2018.214957","journal-title":"Haematologica"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-012-0498-7","article-title":"Increase of novel biomarkers for oxidative stress in patients with plasma cell disorders and in multiple myeloma patients with bone lesions","volume":"61","author":"Gangemi S","year":"2012","unstructured":"Gangemi S, Allegra A, Alonci A, et al.. Increase of novel biomarkers for oxidative stress in patients with plasma cell disorders and in multiple myeloma patients with bone lesions. Inflamm Res. 2012, 61:1063-7. 10.1007\/s00011-012-0498-7","journal-title":"Inflamm Res"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.601699","article-title":"Differentiating between multiple myeloma and metastasis subtypes of lumbar vertebra lesions using machine learning-based radiomics","volume":"11","author":"Xiong X","year":"2021","unstructured":"Xiong X, Wang J, Hu S, Dai Y, Zhang Y, Hu C. Differentiating between multiple myeloma and metastasis subtypes of lumbar vertebra lesions using machine learning-based radiomics. Front Oncol. 2021, 11:601699. 10.3389\/fonc.2021.601699","journal-title":"Front Oncol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-3430","article-title":"A machine learning model based on tumor and immune biomarkers to predict undetectable MRD and survival outcomes in multiple myeloma","volume":"28","author":"Guerrero C","year":"2022","unstructured":"Guerrero C, Puig N, Cedena MT, et al.. A machine learning model based on tumor and immune biomarkers to predict undetectable MRD and survival outcomes in multiple myeloma. Clin Cancer Res. 2022, 28:2598-609. 10.1158\/1078-0432.CCR-21-3430","journal-title":"Clin Cancer Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/445936-artificial-intelligence-in-hematologic-malignancies-opportunities-challenges-and-clinical-integration","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T23:29:57Z","timestamp":1767742197000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/445936-artificial-intelligence-in-hematologic-malignancies-opportunities-challenges-and-clinical-integration"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":50,"URL":"https:\/\/doi.org\/10.7759\/cureus.100950","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,6]]}}}